Brandon Boyd
Family · Lexington, SCNPI 1790430577
Payments from drug & device makers
Across 132 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$414
- AstraZeneca$331
- Novo Nordisk$319
- Dexcom, Inc.$274
- AbbVie$211
- Amgen$128
- plus $708 from 19 others
What the payments were for
- Food & beverage$2,385100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 27 | $414 |
| AstraZeneca | 18 | $331 |
| Novo Nordisk | 18 | $319 |
| Dexcom, Inc. | 8 | $274 |
| AbbVie | 12 | $211 |
| Amgen(2 entities) | 8 | $128 |
| Boehringer Ingelheim | 6 | $98 |
| Exact Sciences | 6 | $92 |
| Pfizer | 4 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Novartis | 3 | $55 |
| Dynavax Technologies Corporation | 3 | $52 |
| Abbott | 2 | $47 |
| Zimmer Biomet | 1 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Bayer | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Halozyme Inc | 1 | $13 |
How this compares
$2,385 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olmesartan Medoxomil | 56 | $1,041 |
| Rosuvastatin Calcium | 61 | $971 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $774 |
| Fluticasone Propionate | 58 | $514 |
| Amlodipine Besylate | 71 | $507 |
| Atorvastatin Calcium | 23 | $488 |
| Omeprazole | 20 | $407 |
| Losartan Potassium | 32 | $390 |
| Ondansetron OdtOndansetron | 23 | $280 |
| Lisinopril | 36 | $261 |
| Ezetimibe | 12 | $259 |
| Metformin Hcl ErMetformin Hcl | 28 | $253 |
| Duloxetine Hcl | 16 | $226 |
| Amoxicillin | 66 | $223 |
| Prednisone | 118 | $210 |
Paid to pharmacies, not to this prescriber.
Other family in Lexington
- Amy LoperLexington$20K
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.